SI0785950T1 - Keratinocyte growth factor analogs - Google Patents

Keratinocyte growth factor analogs

Info

Publication number: SI0785950T1
Authority: SI; Slovenia
Prior art keywords: growth factor; keratinocyte growth; factor analogs; analogs; kgf
Prior art date: 1994-10-13

Application number

SI9530653T

Other languages

English (en)

Slovenian (sl)

Inventor

Bao-Lu Chen

Tsutomu Arakawa

Original Assignee

Amgen Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-13

Filing date

1995-10-12

Publication date

2003-08-31

1995-10-12 Application filed by Amgen Inc. filed Critical Amgen Inc.

2003-08-31 Publication of SI0785950T1 publication Critical patent/SI0785950T1/xx

Links

102000003972 Fibroblast growth factor 7 Human genes 0.000 title 1
108090000385 Fibroblast growth factor 7 Proteins 0.000 title 1
125000000539 amino acid group Chemical group 0.000 abstract 1
150000001413 amino acids Chemical class 0.000 abstract 1
230000037430 deletion Effects 0.000 abstract 1
238000012217 deletion Methods 0.000 abstract 1
102000004169 proteins and genes Human genes 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1
238000006467 substitution reaction Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Gastroenterology & Hepatology (AREA)
Dermatology (AREA)
Emergency Medicine (AREA)
Ophthalmology & Optometry (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Hematology (AREA)
Pulmonology (AREA)
Toxicology (AREA)
Zoology (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Obesity (AREA)
Rheumatology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

SI9530653T 1994-10-13 1995-10-12 Keratinocyte growth factor analogs SI0785950T1 (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US32333794A	1994-10-13	1994-10-13
US48782595A	1995-06-07	1995-06-07
PCT/US1995/013075 WO1996011951A2 (fr)	1994-10-13	1995-10-12	Analogues du facteur de croissance des keratinocytes
EP95938216A EP0785950B1 (fr)	1994-10-13	1995-10-12	Analogues du facteur de croissance des keratinocytes

Publications (1)

Publication Number	Publication Date
SI0785950T1 true SI0785950T1 (en)	2003-08-31

Family

ID=26983900

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI9530653T SI0785950T1 (en)	1994-10-13	1995-10-12	Keratinocyte growth factor analogs

Country Status (14)

Country	Link
EP (1)	EP0785950B1 (fr)
JP (2)	JP4422210B2 (fr)
AT (1)	ATE237634T1 (fr)
AU (1)	AU3893195A (fr)
CA (1)	CA2202390C (fr)
DE (1)	DE69530404T2 (fr)
DK (1)	DK0785950T3 (fr)
ES (1)	ES2196088T3 (fr)
HU (1)	HUT78069A (fr)
MX (1)	MX9702665A (fr)
NO (1)	NO971621L (fr)
PT (1)	PT785950E (fr)
SI (1)	SI0785950T1 (fr)
WO (1)	WO1996011951A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2227527T3 (es)	1993-06-29	2005-04-01	Chiron Corp	Un factor de crecimiento de queratinocitos (kgf) truncado que tiene actividad biologica aumentada.
US7084119B2 (en)	1993-06-29	2006-08-01	Chiron Corporation	Truncated keratinocyte growth factor (KGF) having increased biological activity
CZ98297A3 (cs) *	1994-10-13	1998-08-12	Amgen Inc.	Způsob purifikace keratinocytových růstových faktorů
US6077692A (en)	1995-02-14	2000-06-20	Human Genome Sciences, Inc.	Keratinocyte growth factor-2
US7232667B2 (en)	1995-02-14	2007-06-19	Human Genome Sciences, Inc.	Keratinocyte growth factor-2 polynucleotides
US6693077B1 (en)	1995-02-14	2004-02-17	Human Genome Sciences, Inc.	Keratinocyte growth factor-2
AU720232B2 (en)	1996-07-19	2000-05-25	Amgen, Inc.	Analogs of cationic proteins
EP1473366A1 (fr) *	1996-10-15	2004-11-03	Amgen Inc.	Produits a base du facteur de croissance 2 des keratinocytes
DK0935652T3 (da) *	1996-10-15	2004-07-26	Amgen Inc	Keratinocyt vækstfaktor-2 produkter
US6743422B1 (en)	1996-10-15	2004-06-01	Amgen, Inc.	Keratinocyte growth factor-2 products
EP1041996A4 (fr) *	1997-12-22	2003-05-14	Human Genome Sciences Inc	Formulations du facteur-2 de croissance des keratinocytes
US6869927B1 (en)	1997-12-22	2005-03-22	Human Genome Sciences, Inc.	Keratinocyte growth factor-2 formulations
US6248725B1 (en)	1999-02-23	2001-06-19	Amgen, Inc.	Combinations and methods for promoting in vivo liver cell proliferation and enhancing in vivo liver-directed gene transduction
MXPA04001526A (es)	2001-08-21	2004-05-31	Chiron Corp	Composiciones de polipetidos kgf.
BRPI0519070A2 (pt)	2004-12-15	2008-12-23	Amgen Inc	composiÇço de fator de crescimento de queratinàcito liofilizada, mÉtodos para preparar um fator de crescimento de queratinàcito liofilizado, e para tratar uma doenÇa, e, kit para preparar uma composiÇço farmacÊutica aquosa
KR20230127721A (ko)	2022-02-25	2023-09-01	한국해양과학기술원	온도안정성을 향상시킨 fgf7 폴리펩타이드 및 그 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE197800T1 (de) *	1989-01-31	2000-12-15	Jeffrey S Rubin	Dns kodierend für einen für epithelzellen spezifischen wachstumsfaktor
CA2172137C (fr) *	1993-09-24	1999-12-14	Andrew Peter Seddon	Analogues structurels de facteurs de croissance des fibroblastes, avec sequence en boucle

1995
- 1995-10-12 WO PCT/US1995/013075 patent/WO1996011951A2/fr active IP Right Grant
- 1995-10-12 AU AU38931/95A patent/AU3893195A/en not_active Abandoned
- 1995-10-12 EP EP95938216A patent/EP0785950B1/fr not_active Expired - Lifetime
- 1995-10-12 AT AT95938216T patent/ATE237634T1/de active
- 1995-10-12 CA CA002202390A patent/CA2202390C/fr not_active Expired - Fee Related
- 1995-10-12 DE DE69530404T patent/DE69530404T2/de not_active Expired - Lifetime
- 1995-10-12 HU HU9901325A patent/HUT78069A/hu unknown
- 1995-10-12 DK DK95938216T patent/DK0785950T3/da active
- 1995-10-12 JP JP51337096A patent/JP4422210B2/ja not_active Expired - Fee Related
- 1995-10-12 SI SI9530653T patent/SI0785950T1/xx unknown
- 1995-10-12 MX MX9702665A patent/MX9702665A/es not_active IP Right Cessation
- 1995-10-12 PT PT95938216T patent/PT785950E/pt unknown
- 1995-10-12 ES ES95938216T patent/ES2196088T3/es not_active Expired - Lifetime
1997
- 1997-04-09 NO NO971621A patent/NO971621L/no unknown
2006
- 2006-09-01 JP JP2006237876A patent/JP2007020575A/ja active Pending

Also Published As

Publication number	Publication date
ES2196088T3 (es)	2003-12-16
WO1996011951A2 (fr)	1996-04-25
NO971621L (no)	1997-06-12
PT785950E (pt)	2003-09-30
EP0785950A2 (fr)	1997-07-30
JP2007020575A (ja)	2007-02-01
DK0785950T3 (da)	2003-07-28
CA2202390A1 (fr)	1996-04-25
JP2000511762A (ja)	2000-09-12
CA2202390C (fr)	2005-05-17
MX9702665A (es)	1997-07-31
DE69530404D1 (de)	2003-05-22
DE69530404T2 (de)	2003-11-13
HUT78069A (hu)	1999-08-30
JP4422210B2 (ja)	2010-02-24
ATE237634T1 (de)	2003-05-15
NO971621D0 (no)	1997-04-09
EP0785950B1 (fr)	2003-04-16
AU3893195A (en)	1996-05-06
WO1996011951A3 (fr)	1996-12-12

Publication	Publication Date	Title
SI0785950T1 (en)	2003-08-31	Keratinocyte growth factor analogs
BG101408A (en)	1997-12-30	Analogs of keratinocyte growth factor
AU6286986A (en)	1987-03-10	Peptide analogues of mammalian insulin-like growth factor-1
AU7550098A (en)	1998-12-30	System for expressing hyperthermostable protein
MY123740A (en)	2006-06-30	Il-13 receptor polypeptide
ES2000216A6 (es)	1988-01-16	Procedimiento para preparar un polipeptido purificado que tiene propiedades inhibidoras de la coagulacion de la sangre.
RU94045952A (ru)	1996-10-10	Домен ингибитора протеазы, днк, вектор, клетка, способ получения ингибитора протеазы, фармацевтическая композиция, применение домена
AU4683489A (en)	1990-06-21	Tgf-beta 1/beta 2: a novel chimeric transforming growth factor-beta
ES2095255T3 (es)	1997-02-16	Analogos de sustitucion de peptidos magainina.
AU3258197A (en)	1998-01-07	Peptides
CA2201944A1 (fr)	1996-07-25	Analogues du facteur de croissance des keratinocytes ayant une stabilite de temperature amelioree
CA2133834A1 (fr)	1993-10-14	Mode de preparation de proteines modifiees
EP0330700A4 (fr)	1990-01-08	Polypeptide ressemblant à la prourokinase humaine.
EP0249412A3 (en)	1989-02-22	C-terminal alpha-amidating enzyme and process for production and use thereof
NZ511618A (en)	2003-06-30	Kininogen fragment 2 peptides with the formula of at least X-His-Lys-X-Lys-X
GR3021408T3 (en)	1997-01-31	Cloning of a new member of the fibroblast growth factor (fgf) receptor family
DK0828004T3 (da)	2007-03-19	Proteindisulfidisomerase-gen afledt af stamme af methylotrof gær
ATE224403T1 (de)	2002-10-15	Verwendung von kaseinfragmenten als wachstumerförderer
EP1295943A4 (fr)	2005-11-16	Polypeptides capables le pouvoir de stimuler les neutrophiles
EP0625580A4 (en)	1994-12-21	Novel hirudine variant, process for producing the same, and anticoagulant containing the same as active ingredient.
EP1158052A4 (fr)	2002-10-02	Gene de beta-primeverosidasde
MX9709921A (es)	1998-08-30	Alfa-d-galactosidasas de glicina y phaseolus.
MX9700656A (es)	1998-01-31	Proceso novedoso para la produccion de proteina dimerica biologicamente activa.